An adenoviral vector encoded with the GPx-1 gene attenuates memory impairments induced by β-amyloid (1-42) in GPx-1 KO mice via activation of M1 mAChR-mediated signalling

References

• Behl C, Davis JB, Lesley R, et al. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell. 1994;77(6):817–827.
   PubMed Web of Science ®Google Scholar
• Butterfield DA. Amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity: Implications for neurodegeneration in Alzheimer’s disease brain. A review. Free Radic Res. 2002;36:1307–1313.
   PubMed Web of Science ®Google Scholar
• Jhoo JH, Kim HC, Nabeshima T, et al. Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex. Behav Brain Res. 2004;155(2):185–196.
   PubMed Web of Science ®Google Scholar
• Kim HC, Yamada K, Nitta A, et al. Immunocytochemical evidence that amyloid beta (1-42) impairs endogenous antioxidant systems in vivo. Neuroscience. 2003;119(2):399–419.
   PubMed Web of Science ®Google Scholar
• Wang WT, Tailor BA, Cohen DS, et al. Alzheimer’s pathogenesis, metal-mediated redox stress, and potential nanotheranostics. EC Pharmacol Toxicol. 2019;7:547–558.
   PubMedGoogle Scholar
• Butterfield DA. The 2013 SFRBM discovery award: Selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment. Free Radic Biol Med. 2014;74:157–174.
   PubMed Web of Science ®Google Scholar
• Butterfield DA. Perspectives on oxidative stress in Alzheimer's disease and predictions of future research emphases. J Alzheimers Dis. 2018;64(s1):S469–S479.
   PubMedGoogle Scholar
• Butterfield DA, Drake J, Pocernich C, et al. Evidence of oxidative damage in Alzheimer’s disease brain: central role for amyloid beta-peptide. Trends Mol Med. 2001;7(12):548–554.
   PubMed Web of Science ®Google Scholar
• Mattson MP. Free radicals and disruption of neuronal ion homeostasis in AD: A role for amyloid beta-peptide? Neurobiol Aging. 1995;16(4):679–682.
   PubMed Web of Science ®Google Scholar
• Behl C, Davis J, Cole GM, et al. Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem Biophys Res Commun. 1992;186(2):944–950.
   PubMed Web of Science ®Google Scholar
• Li MH, Jang JH, Sun B, et al. Protective effects of oligomers of grape seed polyphenols against beta-amyloid-induced oxidative cell death. Ann N Y Acad Sci. 2004;1030:317–329.
   PubMed Web of Science ®Google Scholar
• Jang JH, Surh YJ. Protective effect of resveratrol on β-amyloid-induced oxidative PC12 cell death. Free Radic Biol Med. 2003;34(8):1100–1110.
   PubMed Web of Science ®Google Scholar
• Shin E-J, Oh K-W, Kim K-W, et al. Attenuation of cocaine-induced conditioned place preference by Polygala tenuifolia root extract. Life Sci. 2004;75(23):2751–2764.
   PubMed Web of Science ®Google Scholar
• Li Z-Y, Chung YH, Shin E-J, et al. YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2. J Neuroinflammation. 2017;14(1):94.
   PubMed Web of Science ®Google Scholar
• Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem. 1992;59(5):1609–1623.
   PubMed Web of Science ®Google Scholar
• Sani M, Sebaï H, Gadacha W, et al. Catalase activity and rhythmic patterns in mouse brain, kidney and liver. Comp Biochem Physiol B Biochem Mol Biol. 2006;145(3-4):331–337.
   PubMed Web of Science ®Google Scholar
• Power JHT, Blumbergs PC. Cellular glutathione peroxidase in human brain: Cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson's disease and dementia with Lewy bodies. Acta Neuropathol. 2009;117(1):63–73.
   PubMed Web of Science ®Google Scholar
• Margis R, Dunand C, Teixeira FK, et al. Glutathione peroxidase family - an evolutionary overview. Febs J. 2008;275(15):3959–3970.
   PubMed Web of Science ®Google Scholar
• Hampel H, Mesulam MM, Cuello AC, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. Brain. 2018;141(7):1917–1933.
   PubMed Web of Science ®Google Scholar
• Bartus RT. On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol. 2000;163(2):495–529.
   PubMed Web of Science ®Google Scholar
• Kihara T, Shimohama S. Alzheimer’s disease and acetylcholine receptors. Acta Neurobiol Exp (Wars)). 2004;64(1):99–105.
   PubMed Web of Science ®Google Scholar
• Fisher A. M1 muscarinic agonists target major hallmarks of Alzheimer's disease-the pivotal role of brain M1 receptors. Neurodegener Dis. 2008;5(3–4):237–240.
   PubMed Web of Science ®Google Scholar
• Jiang S, Li Y, Zhang C, et al. M1 muscarinic acetylcholine receptor in Alzheimer's disease. Neurosci Bull. 2014;30(2):295–307.
   PubMed Web of Science ®Google Scholar
• Lu B, Nagappan G, Lu Y. BDNF and synaptic plasticity, cognitive function, and dysfunction. Handb Exp Pharmacol. 2015;220:223–250.
   Google Scholar
• Nabeshima T, Yamada K. Neurotrophic factor strategies for the treatment of Alzheimer disease. Alzheimer Dis Assoc Disord. 2000;14:S39–S46.
   PubMed Web of Science ®Google Scholar
• Schindowski K, Belarbi K, Buée L. Neurotrophic factors in Alzheimer’s disease: role of axonal transport. Genes, Brain Behav. 2008;7:43–56.
   PubMed Web of Science ®Google Scholar
• Tuszynski MH. Nerve growth factor gene therapy in Alzheimer disease. Alzheimer Dis Assoc Disord. 2007;21(2):179–189.
   PubMed Web of Science ®Google Scholar
• Einoch R, Weinreb O, Mandiuk N, et al. The involvement of BDNF-CREB signaling pathways in the pharmacological mechanism of combined SSRI- antipsychotic treatment in schizophrenia. Eur Neuropsychopharmacol. 2017;27(5):470–483.
   PubMed Web of Science ®Google Scholar
• Pizzorusso T, Ratto GM, Putignano E, et al. Brain-derived neurotrophic factor causes cAMP response element-binding protein phosphorylation in absence of calcium increases in slices and cultured neurons from rat visual cortex. J Neurosci. 2000;20(8):2809–2816.
   PubMed Web of Science ®Google Scholar
• Alonso M, Bekinschtein P, Cammarota M, et al. Endogenous BDNF is required for long-term memory formation in the rat parietal cortex. Learn Mem. 2005;12(5):504–510.
   PubMed Web of Science ®Google Scholar
• Gooney M, Messaoudi E, Maher FO, et al. BDNF-induced LTP in dentate gyrus is impaired with age: analysis of changes in cell signaling events. Neurobiol Aging. 2004;25(10):1323–1331.
   PubMed Web of Science ®Google Scholar
• Ying SW, Futter M, Rosenblum K, et al. Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: Requirement for ERK activation coupled to CREB and upregulation of Arc synthesis. J Neurosci. 2002;22(5):1532–1540.
   PubMed Web of Science ®Google Scholar
• Gil-Bea FJ, Solas M, Mateos L, et al. Cholinergic hypofunction impairs memory acquisition possibly through hippocampal Arc and BDNF downregulation. Hippocampus. 2011;21(9):999–1009.
   PubMed Web of Science ®Google Scholar
• Ho YS, Magnenat JL, Bronson RT, et al. Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J Biol Chem. 1997;272(26):16644–16651.
   PubMed Web of Science ®Google Scholar
• Cheng WH, Ho YS, Ross DA, et al. Cellular glutathione peroxidase knockout mice express normal levels of selenium-dependent plasma and phospholipid hydroperoxide glutathione peroxidases in various tissues. J Nutr. 1997;127(8):1445–1450.
   PubMed Web of Science ®Google Scholar
• Pham DT, Chung YH, Mai HN, et al. Glutathione peroxidase-1 gene rescues cocaine-induced conditioned place preference in mice by inhibiting σ-1 receptor expression. Clin Exp Pharmacol Physiol. 2019;46(9):791–797.
   PubMed Web of Science ®Google Scholar
• Nguyen LTT, Nguyen TXK, Bach JH, et al. Glutathione peroxidase-1 gene depletion potentiates cognitive impairments induced by β-amyloid (1-42). Proceedings of the spring international convention of the pharmaceutical society of Korea [April 21-22, Busan Exhibition & Convention Center (BEXCO)]. 2011; P168.
   Google Scholar
• Yoo MH, Gu X, Xu XM, et al. Delineating the role of glutathione peroxidase 4 in protecting cells against lipid hydroperoxide damage and in Alzheimer's disease. Antioxid Redox Signal. 2010;12(7):819–827.
   PubMed Web of Science ®Google Scholar
• Zhang L, Fang Y, Lian Y, et al. Brain-derived neurotrophic factor ameliorates learning deficits in a rat model of Alzheimer's disease induced by aβ1-42. PLoS One. 2015;10(4):e0122415
   PubMed Web of Science ®Google Scholar
• Zhang L, Fang Y, Xu Y, et al. Curcumin improves amyloid β-peptide (1-42) induced spatial memory deficits through BDNF-ERK signaling pathway. PLoS One. 2015;10(6):e0131525.
   PubMed Web of Science ®Google Scholar
• Zhang T, Chen D, Lee TH. Molecular sciences phosphorylation signaling in APP processing in Alzheimer’s disease. IJMS. 2019;21(1):209.
   Google Scholar
• Zhang T, Chen D, Lee TH. Phosphorylation signaling in APP processing in Alzheimer’s disease. Int J Mol Sci. 2020;21:209.
   Web of Science ®Google Scholar
• Shin E-J, Jhoo JH, Nabeshima T, et al. Growth hormone releaser attenuates beta-amyloid (1–42)-induced memory impairment in mice. J Pharmacol Sci. 2005;99(1):117–120.
   PubMed Web of Science ®Google Scholar
• Shin EJ, Chae JS, Park SJ, et al. Growth hormone-releaser diet attenuates beta-amyloid(1-42)-induced cognitive impairment via stimulation of the insulin-like growth factor (IGF)-1 receptor in mice. J Pharmacol Sci. 2009;109(1):139–143.
   PubMed Web of Science ®Google Scholar
• Yeung JHY, Palpagama TH, Tate WP, et al. The acute effects of amyloid-beta1–42 on glutamatergic receptor and transporter expression in the mouse hippocampus. Front Neurosci. 2020;13:1427.
   PubMed Web of Science ®Google Scholar
• Calvo-Flores Guzmán B, Elizabeth Chaffey T, Hansika Palpagama T, et al. The interplay between beta-amyloid 1–42 (Aβ1–42)-induced hippocampal inflammatory response, p-tau, vascular pathology, and their synergistic contributions to neuronal death and behavioral deficits. Front Mol Neurosci. 2020;13:196.
   Web of Science ®Google Scholar
• He TC, Zhou S, Da Costa LT, et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA. 1998;95(5):2509–2514.
   PubMed Web of Science ®Google Scholar
• Jin CH, Shin EJ, Park JB, et al. Fustin flavonoid attenuates beta-amyloid (1-42)-induced learning impairment. J Neurosci Res. 2009;87(16):3658–3670.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Shin EJ, Lee BH, et al. Oral administration of gintonin attenuates cholinergic impairments by scopolamine, amyloid-β protein, and mouse model of Alzheimer's disease. Mol Cells. 2015;38(9):796–805.
   PubMed Web of Science ®Google Scholar
• Chao LP, Wolfgram F. Spectrophotometric assay for choline acetyltransferase. Anal Biochem. 1972;46(1):114–118.
   PubMed Web of Science ®Google Scholar
• Mai HN, Sharma N, Shin E-J, et al. Exposure to far-infrared rays attenuates methamphetamine-induced recognition memory impairment via modulation of the muscarinic M1 receptor, Nrf2, and PKC. Neurochem Int. 2018;116:63–76.
   PubMed Web of Science ®Google Scholar
• Tran T-V, Shin E-J, Jeong JH, et al. Protective potential of the glutathione peroxidase-1 gene in abnormal behaviors induced by phencyclidine in mice. Mol Neurobiol. 2017;54(9):7042–7062.
   PubMed Web of Science ®Google Scholar
• Shin EJ, Nam Y, Tu THT, et al. Protein kinase Cδ mediates trimethyltin-induced neurotoxicity in mice in vivo via inhibition of glutathione defense mechanism. Arch Toxicol. 2016;90(4):937–953.
   PubMed Web of Science ®Google Scholar
• Nguyen BT, Sharma N, Shin E-J, et al. Theanine attenuates memory impairments induced by klotho gene depletion in mice. Food Funct. 2019;10(1):325–332.
   PubMed Web of Science ®Google Scholar
• Mai HN, Sharma N, Shin E-J, et al. Exposure to far-infrared ray attenuates methamphetamine-induced impairment in recognition memory through inhibition of protein kinase C δ in male mice: Comparison with the antipsychotic clozapine. J Neurosci Res. 2018;96:1294–1310.
   PubMed Web of Science ®Google Scholar
• Tran TV, Shin EJ, Nguyen LTT, et al. Protein kinase Cδ gene depletion protects against methamphetamine-induced impairments in recognition memory and ERK1/2 signaling via upregulation of glutathione peroxidase-1 gene. Mol Neurobiol. 2018;55(5):4136–4159.
   PubMed Web of Science ®Google Scholar
• Nagai T, Yamada K, Kim HC, et al. Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress. Faseb J. 2003;17(1):50–52.
   PubMedGoogle Scholar
• Castro MG, Candolfi M, Wilson TJ, et al. Adenoviral vector-mediated gene therapy for gliomas: coming of age. Expert Opin Biol Ther. 2014;14(9):1241–1257.
   PubMed Web of Science ®Google Scholar
• Kantor B, Bailey RM, Wimberly K, et al. Methods for gene transfer to the central nervous system. Advances in genetics. 2014; 125–197.
   Google Scholar
• Lentz TB, Gray SJ, Samulski RJ. Viral vectors for gene delivery to the central nervous system. Neurobiol Dis. 2012;48(2):179–188.
   PubMed Web of Science ®Google Scholar
• Nakajima A, Aoyama Y, Shin EJ, et al. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD)). Behav Brain Res. 2015;289:69–77.
   PubMed Web of Science ®Google Scholar
• Ma X-H, Zhong P, Gu Z, et al. Muscarinic potentiation of GABA(A) receptor currents is gated by insulin signaling in the prefrontal cortex. J Neurosci. 2003;23(4):1159–1168.
   PubMed Web of Science ®Google Scholar
• Levey AI, Kitt CA, Simonds WF, et al. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci. 1991;11(10):3218–3226.
   PubMed Web of Science ®Google Scholar
• Lebois EP, Thorn C, Edgerton JR, et al. Muscarinic receptor subtype distribution in the central nervous system and relevance to aging and Alzheimer's disease. Neuropharmacology. 2018;136(Pt C):362–373.
   PubMedGoogle Scholar
• Wolf BA, Wertkin AM, Jolly YC, et al. Muscarinic regulation of Alzheimer's disease amyloid precursor protein secretion and amyloid beta-protein production in human neuronal NT2N cells. J Biol Chem. 1995;270(9):4916–4922.
   PubMed Web of Science ®Google Scholar
• Nitsch RM, Slack BE, Wurtman RJ, et al. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science. 1992;258(5080):304–307.
   PubMed Web of Science ®Google Scholar
• Haring R, Fisher A, Marciano D, et al. Mitogen-activated protein kinase-dependent and protein kinase C-dependent pathways link the m1 Muscarinic receptor to beta-amyloid precursor protein secretion. J Neurochem. 1998;71(5):2094–2103.
   PubMed Web of Science ®Google Scholar
• Farías GG, Godoy JA, Hernández F, et al. M1 muscarinic receptor activation protects neurons from beta-amyloid toxicity. A role for Wnt signaling pathway. Neurobiol Dis. 2004;17(2):337–348.
   PubMed Web of Science ®Google Scholar
• Caccamo A, Oddo S, Billings LM, et al. M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron. 2006;49(5):671–682.
   PubMed Web of Science ®Google Scholar
• Chintamaneni PK, Krishnamurthy PT, Rao PV, et al. Surface modified nano-lipid drug conjugates of positive allosteric modulators of M1 muscarinic acetylcholine receptor for the treatment of Alzheimer's disease. Med Hypotheses. 2017;101:17–22.
   PubMed Web of Science ®Google Scholar
• Fisher A. M1 muscarinic agonists target major hallmarks of Alzheimer's disease-an update. Curr Alzheimer Res. 2007;4(5):577–580.
   PubMed Web of Science ®Google Scholar
• Tzavara ET, Bymaster FP, Felder CC, et al. Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice. Mol Psychiatry. 2003;8(7):673–679.
   PubMed Web of Science ®Google Scholar
• Mulugeta E, Karlsson E, Islam A, et al. Loss of muscarinic M4 receptors in hippocampus of Alzheimer patients. Brain Res. 2003;960(1-2):259–262.
   PubMed Web of Science ®Google Scholar
• Kihara T, Shimohama S, Urushitani M, et al. Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity. Brain Res. 1998;792(2):331–334.
   PubMed Web of Science ®Google Scholar
• Levin ED, Bradley A, Addy N, et al. Hippocampal α7 and α4β2 nicotinic receptors and working memory. Neuroscience. 2002;109(4):757–765.
   PubMed Web of Science ®Google Scholar
• Corrigan FM, Van Rhijn AG, Ijomah G, et al. Tin and fatty acids in dementia. Prostaglandins, Leukot Essent Fat Acids. 1991;43(4):229–238.
   PubMed Web of Science ®Google Scholar
• Martin F, Corrigan FM, Donard OF, et al. Organotin compounds in trimethyltin-treated rats and in human brain in Alzheimer's disease. Hum Exp Toxicol. 1997;16(9):512–515.
   PubMed Web of Science ®Google Scholar
• Liu M, Sun A, Shin E-J, et al. Expression of microsomal epoxide hydrolase is elevated in Alzheimer's hippocampus and induced by exogenous beta-amyloid and trimethyl-tin. Eur J Neurosci. 2006;23(8):2027–2034.
   PubMed Web of Science ®Google Scholar
• Andjus PR, Bataveljić D, Vanhoutte G, et al. In vivo morphological changes in animal models of amyotrophic lateral sclerosis and Alzheimer's-like disease: MRI approach. Anat Rec (Hoboken)). 2009;292(12):1882–1892.
   PubMedGoogle Scholar
• Kassed CA, Butler TL, Navidomskis MT, et al. Mice expressing human mutant presenilin-1 exhibit decreased activation of NF-κB p50 in hippocampal neurons after injury. Brain Res Mol Brain Res. 2003;110(1):152–157.
   PubMedGoogle Scholar
• Kim BK, Tran HYP, Shin EJ, et al. IL-6 attenuates trimethyltin-induced cognitive dysfunction via activation of JAK2/STAT3, M1 mAChR and ERK signaling network. Cell Signal. 2013;25(6):1348–1360.
   PubMed Web of Science ®Google Scholar
• Park SJ, Shin EJ, Min SS, et al. Inactivation of JAK2/STAT3 signaling axis and downregulation of m1 mAChR cause cognitive impairment in klotho mutant mice, a genetic model of aging. Neuropsychopharmacology. 2013;38(8):1426–1437.
   PubMed Web of Science ®Google Scholar
• Kuro-O M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390(6655):45–51.
   PubMed Web of Science ®Google Scholar
• Hellweg R, Jockers-Scherübl M. Neurotrophic factors in memory disorders. Life Sci. 1994;55(25-26):2165–2169.
   PubMed Web of Science ®Google Scholar
• Thöne J, Ellrichmann G, Seubert S, et al. Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor. Am J Pathol. 2012;180(1):267–274.
   PubMed Web of Science ®Google Scholar
• Tong L, Thornton PL, Balazs R, et al. Beta -amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival Is not compromised. J Biol Chem. 2001;276(20):17301–17306.
   PubMed Web of Science ®Google Scholar
• Cheng WH, Ho YS, Valentine BA, et al. Cellular glutathione peroxidase is the mediator of body selenium to protect against paraquat lethality in transgenic mice. J Nutr. 1998;128(7):1070–1076.
   PubMed Web of Science ®Google Scholar
• Martini F, Rosa SG, Klann IP, et al. A multifunctional compound ebselen reverses memory impairment, apoptosis and oxidative stress in a mouse model of sporadic Alzheimer's disease. J Psychiatr Res. 2019;109:107–117.
   PubMed Web of Science ®Google Scholar
• Martini F, Pesarico AP, Brüning CA, et al. Ebselen inhibits the activity of acetylcholinesterase globular isoform G4 in vitro and attenuates scopolamine-induced amnesia in mice. J Cell Biochem. 2018;119(7):5598–5608.
   PubMed Web of Science ®Google Scholar
• Xie Y, Tan Y, Zheng Y, et al. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice. J Biol Inorg Chem. 2017;22(6):851–865.
   PubMed Web of Science ®Google Scholar